{"Symbol": "OXFD", "AssetType": "Common Stock", "Name": "Oxford Immunotec Global PLC", "Description": "Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT.TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT.CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions. Oxford Immunotec Global PLC was founded in 2002 and is headquartered in Abingdon, the United Kingdom.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Diagnostics & Research", "Address": "143 Park Drive, Abingdon, United Kingdom, OX14 4SE", "FullTimeEmployees": "260", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "353254336", "EBITDA": "-10253000", "PERatio": "11.746", "PEGRatio": "0", "BookValue": "7.278", "DividendPerShare": "None", "DividendYield": "0", "EPS": "5.18", "RevenuePerShareTTM": "2.247", "ProfitMargin": "-0.2812", "OperatingMarginTTM": "-0.2929", "ReturnOnAssetsTTM": "-0.0482", "ReturnOnEquityTTM": "-0.0755", "RevenueTTM": "59079000", "GrossProfitTTM": "54422000", "DilutedEPSTTM": "-0.632", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-0.702", "AnalystTargetPrice": "18.33", "TrailingPE": "11.746", "ForwardPE": "0", "PriceToSalesRatioTTM": "6.1367", "PriceToBookRatio": "1.8949", "EVToRevenue": "3.391", "EVToEBITDA": "0", "Beta": "1.0467", "52WeekHigh": "17.77", "52WeekLow": "8.37", "50DayMovingAverage": "13.7767", "200DayMovingAverage": "12.5911", "SharesOutstanding": "25955500", "SharesFloat": "20532364", "SharesShort": "551187", "SharesShortPriorMonth": "564913", "ShortRatio": "4.24", "ShortPercentOutstanding": "0.02", "ShortPercentFloat": "0.0247", "PercentInsiders": "18.03", "PercentInstitutions": "101.641", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "None", "LastSplitDate": "None"}